Alternative names : Winstrol, Stanozolol, Oral-Winstrol
Packaging : 100tabs 10mg/tab.
Dosage: 10 - 50mg / day
Winstrol (anabolic steroids) , brand of Stanozolol tablets, is an anabolic steroid, a synthetic derivative of testosterone. Each tablet for oral administration contains 2 mg of Stanozolol. It is designated chemically as 17-methyl-2' H -5(alpha)-androst-2-eno[3,2- c ]pyrazol-17(beta)-ol.
Inactive Ingredients: Dibasic Calcium Phosphate, D&C Red #28, FD&C Red #40, Lactose, Magnesium Stearate, Starch.
Side effects :
WINSTROL (anabolic steroids) , brand of stanozolol tablets, is an anabolic steroid, a synthetic derivative of testosterone. Each tablet for oral administration contains 2 mg of stanozolol. It is designated chemically as 17-methyl-2' H -5(alpha)-androst-2-eno[3,2- c ]pyrazol-17(beta)-ol. Inactive Ingredients: Dibasic Calcium Phosphate, D&C Red #28, FD&C Red #40, Lactose, Magnesium Stearate, Starch. Indications & Dosage INDICATIONS Hereditary Angioedema. WINSTROL (anabolic steroids) is indicated prophylactically to decrease the frequency and severity of attacks of angioedema. DOSAGE AND ADMINISTRATION The use of anabolic steroids may be associated with serious adverse reactions, many of which are dose related; therefore, patients should be placed on the lowest possible effective dose. Hereditary Angioedema. The dosage requirements for continuous treatment of hereditary angioedema with WINSTROL (anabolic steroids) should be individualized on the basis of the clinical response of the patient. It is recommended that the patient be started on 2 mg, three times a day. After a favorable initial response is obtained in terms of prevention of episodes of edematous attacks, the proper continuing dosage should be determined by decreasing the dosage at intervals of one to three months to a maintenance dosage of 2 mg a day. Some patients may be successfully managed on a 2 mg alternate day schedule. During the dose adjusting phase, close monitoring of the patient's response is indicated, particularly if the patient has a history of airway involvement. The prophylactic dose of WINSTROL (anabolic steroids) , to be used prior to dental extraction, or other traumatic or stressful situations has not been established and may be substantially larger. Attacks of hereditary angioedema are generally infrequent in childhood and the risks from stanozolol administration are substantially increased. Therefore, long-term prophylactic therapy with this drug is generally not recommended in children, and should only be undertaken with due consideration of the benefits and risks involved (see PRECAUTIONS, Pediatric Use ). HOW SUPPLIED WINSTROL (anabolic steroids) tablets for oral administration are pink, round tablets scored on one side. Bottles of 100 NDC 0024-2253-04 Store at controlled room temperature 15° to 30° C (59° to 86° F) SLIDESHOW Skin Cancer Symptoms, Types, Images See Slideshow Side Effects & Drug Interactions SIDE EFFECTS Hepatic: Cholestatic jaundice with, rarely, hepatic necrosis and death. Hepatocellular neoplasms and peliosis hepatis have been reported in association with long-term androgenic-anabolic steroid therapy (see WARNINGS). Reversible changes in liver function tests also occur including increased bromsulphalein (BSP) retention and increases in serum bilirubin, glutamic oxaloacetic transaminase (SGOT), and alkaline phosphatase. Genitourinary System: In men. Prepubertal: Phallic enlargement and increased frequency of erections. Postpubertal: Inhibition of testicular function, testicular atrophy and oligospermia, impotence, chronic priapism, epididymitis and bladder irritability. In women: Clitoral enlargement, menstrual irregularities. In both sexes: Increased or decreased libido. CNS: Habituation, excitation, insomnia, depression. Gastrointestinal: Nausea, vomiting, diarrhea. Hematologic: Bleeding in patients on concomitant anticoagulant therapy. Breast: Gynecomastia. Larynx: Deepening of the voice in women. Hair: Hirsutism and male pattern baldness in women. Skin: Acne (especially in women and prepubertal boys). Skeletal: Premature closure of epiphyses in children (see PRECAUTIONS, Pediatric Use ). Fluid and Electrolytes: Edema, retention of serum electrolytes (sodium, chloride, potassium, phosphate, calcium). Metabolic/Endocrine: Decreased glucose tolerance (see PRECAUTIONS), increased serum levels of low-density lipoproteins and decreased levels of high-density lipoproteins (see PRECAUTIONS, Laboratory Tests ), increased creatine and creatinine excretion, increased serum levels of creatinine phosphokinase (CPK). Some virilizing changes in women are irreversible even after prompt discontinuance of therapy and are not prevented by concomitant use of estrogens (see PRECAUTIONS).
Check out our complete list of ORAL STEROIDS